Ata Inc. ADR buy krebskrebs
Start price
09.09.20
/
50%
€0.90
Target price
04.11.21
€1.20
Performance (%)
128.89%
End price
05.11.21
€2.06
Summary
This prediction ended on 05.11.21 with a price of €2.06. With a performance of 128.89% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ata Inc. ADR | 16.154% | 16.154% | -28.095% | -61.082% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by krebskrebs for this prediction
In the thread Ata Inc. ADR diskutieren
Buy mit Kursziel 1,2
In the thread Trading Ata Inc. ADR
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten